Antileishmanial efficacy of fluconazole and miltefosine in combination with an immunomodulator-picrolivSHAKYA, Nishi; SANE, Shraddha A; GUPTA, Suman et al.Parasitology research (1987). 2011, Vol 108, Num 4, pp 793-800, issn 0932-0113, 8 p.Article

Weak Cytotoxic Activity of Miltefosine Against Clinical Isolates of Acanthamoeba sppMRVA, M; GARAJOVA, M; LUKAC, M et al.The Journal of parasitology. 2011, Vol 97, Num 3, pp 538-540, issn 0022-3395, 3 p.Article

Leishmanicidal activity of edelfosine, miltefosine and ilmofosineAZZOUZ, Samira; MAACHE, Mimoun; GARCIA, Ramon Gil et al.Basic & clinical pharmacology & toxicology (Print). 2005, Vol 96, Num 1, pp 60-65, issn 1742-7835, 6 p.Article

Effects of miltefosine on the proliferation, ultrastructure, and phospholipid composition of Angomonas deanei, a trypanosomatid protozoan that harbors a symbiotic bacteriumDE FREITAS-JUNIOR, Paulo R. G; CATTA-PRETA, Carolina M. C; DA SILVA ANDRADE, Lamara et al.FEMS microbiology letters. 2012, Vol 333, Num 2, pp 129-137, issn 0378-1097, 9 p.Article

Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine)SEIFERT, Karin; MATU, Sangeeta; PEREZ-VICTORIA, F. Javier et al.International journal of antimicrobial agents. 2003, Vol 22, Num 4, pp 380-387, issn 0924-8579, 8 p.Article

Aspects of the cytological activity of edelfosine, miltefosine, and ilmofosine in Leishmania donovaniAZZOUZ, S; MAACHE, M; DOS SANTOS, M. F et al.The Journal of parasitology. 2006, Vol 92, Num 5, pp 877-883, issn 0022-3395, 7 p.Article

In vitro and in vivo interactions between miltefosine and other antileishmanial drugsSEIFERT, Karin; CROFT, Simon L.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 1, pp 73-79, issn 0066-4804, 7 p.Article

Effect of the lysophospholipid analogues edelfosine, ilmofosine and miltefosine against Leishmania amazonensisSANTA-RITA, Ricardo M; HENRIQUES-PONS, Andréa; BARBOSA, Helene S et al.Journal of antimicrobial chemotherapy (Print). 2004, Vol 54, Num 4, pp 704-710, issn 0305-7453, 7 p.Article

Oral miltefosine treatment in children with mild to moderate Indian visceral leishmaniasisSUNDAR, Shyam; JHA, T. K; SINDERMANN, Herbert et al.The Pediatric infectious disease journal. 2003, Vol 22, Num 5, pp 434-438, issn 0891-3668, 5 p.Article

Identification of a Leishmania infantum gene mediating resistance to miltefosine and Sb^IIICHOUDHURY, Kohelia; ZANDER, Dorothea; KUBE, Michael et al.International journal for parasitology. 2008, Vol 38, Num 12, pp 1411-1423, issn 0020-7519, 13 p.Article

Miltefosine (impavido): The first oral treatment against leishmaniasisSINDERMANN, H; CROFT, S. L; ENGEL, K. R et al.Medical microbiology and immunology. 2004, Vol 193, Num 4, pp 173-180, issn 0300-8584, 8 p.Article

Miltefosine enhances phagocytosis but decreases nitric oxide production by peritoneal macrophages of C57BL/6 miceBARRETO PONTE, Charlene; ROCHA ALVES, Erica Alessandra; RIBEIRO SAMPAIO, Raimunda Nonata et al.International immunopharmacology (Print). 2012, Vol 13, Num 1, pp 114-119, issn 1567-5769, 6 p.Article

Quantification of the response to miltefosine treatment for visceral leishmaniasis by QT-NASBADE VRIES, P. J; VAN DER MEIDE, W. F; GODFRIED, M. H et al.Transactions of the Royal Society of Tropical Medicine and Hygiene. 2006, Vol 100, Num 12, pp 1183-1186, issn 0035-9203, 4 p.Article

In vivo activity of perifosine against Leishmania amazonensisGABRIELA CABRERA-SERRA, M; VALLADARES, Basilio; PINERO, Jose E et al.Acta tropica. 2008, Vol 108, Num 1, pp 20-25, issn 0001-706X, 6 p.Article

Intestinal absorption of miltefosine : Contribution of passive paracellular transportMENEZ, Cecile; BUYSE, Marion; DUGAVE, Christophe et al.Pharmaceutical research. 2007, Vol 24, Num 3, pp 546-554, issn 0724-8741, 9 p.Article

Adherence to miltefosine treatment for visceral leishmaniasis under routine conditions in NepalURANW, Surendra; OSTYN, Bart; DORLO, Thomas P. C et al.TM & IH. Tropical medicine & international health. 2013, Vol 18, Num 2, pp 179-187, issn 1360-2276, 9 p.Article

Effects of miltefosine treatment in fibroblast cell cultures and in mice experimentally infected with Neospora caninum tachyzoitesDEBACHE, Karim; HEMPHILL, Andrew.Parasitology (London. Print). 2012, Vol 139, Num 7, pp 934-944, issn 0031-1820, 11 p.Article

Giardia lamblia: A new target for miltefosineEISSA, Maha M; AMER, Eglal I.International journal for parasitology. 2012, Vol 42, Num 5, pp 443-452, issn 0020-7519, 10 p.Article

Effects of topical treatment with the raft modulator miltefosine and clobetasol in cutaneous mastocytosis: a randomized, double-blind, placebo-controlled trialHARTMANN, K; SIEBENHAAR, F; MAURER, M et al.British journal of dermatology (1951). 2010, Vol 162, Num 1, pp 185-190, issn 0007-0963, 6 p.Article

Miltefosine: a novel treatment option for mast cell-mediated diseasesMAURER, Marcus; MAGERL, Markus; METZ, Martin et al.Journal of dermatological treatment. 2013, Vol 24, Num 4, pp 244-249, issn 0954-6634, 6 p.Article

Improved treatment of visceral leishmaniasis (kala-azar) by using combination of ketoconazole, miltefosine with an immunomodulator-PicrolivSHAKYA, Nishi; SANE, Shraddha A; VISHWAKARMA, Preeti et al.Acta tropica. 2011, Vol 119, Num 2-3, pp 188-193, issn 0001-706X, 6 p.Article

Miltefosine, a promising novel agent for schistosomiasis mansoniEISSA, Maha M; EL-AZZOUNI, Mervat Z; AMER, Eglal I et al.International journal for parasitology. 2011, Vol 41, Num 2, pp 235-242, issn 0020-7519, 8 p.Article

Sitamaquine Overcomes ABC-Mediated Resistance to Miltefosine and Antimony in LeishmaniaPEREZ- VICTORIA, Jose M; BAVCHVAROV, Boris I; TORRECILLAS, Iván R et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 8, pp 3838-3844, issn 0066-4804, 7 p.Article

Efficacy of Miltefosine for the Treatment of American Cutaneous LeishmaniasisVELEZ, Iván; LOPEZ, Liliana; SANCHEZ, Ximena et al.The American journal of tropical medicine and hygiene. 2010, Vol 83, Num 2, pp 351-356, issn 0002-9637, 6 p.Article

Possible mechanism of miltefosine-mediated death of Leishmania donovaniVERMA, Navin K; DEY, Chinmoy S.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 8, pp 3010-3015, issn 0066-4804, 6 p.Article